ºÚÁÏÍø

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

The dual opposite effects of cilostazol on fertility: An animal model

2nd International Summit on Clinical Pharmacy

Ahmed M Taiyeb

ScientificTracks Abstracts: Clinic Pharmacol Biopharm

DOI:

Abstract
The current contraceptive pills are associated with cardiovascular and cancer diseases because of their steroidal nature. While scientific research has developed many antibiotics and antihypertensive drugs using different pharmacological approaches, the pharmacological development of contraceptive medications that is not steroidal in nature has yet to be achieved. Cilostazol (CLZ) is a phosphodiesterase IIIA inhibitor that is prescribed for patients with intermittent claudication (Pletal®). Using the mouse animal model, we found that CLZ is capable of inhibiting oocyte maturation in vitro, in vivo, and to block pregnancy in naturally cycling mice (P<0.0001). CLZ results in ovulation of immature oocytes that cannot be fertilized. This contraceptive approach is different from that of steroidal contraceptives, which impairs follicular development and blocks ovulation. We then allowed for ovulated immature oocytes to mature in vitro or in the oviducts. We found these oocytes are of advanced cytoplasmic and nuclear maturation and higher fertilization rates when compared with ovulated mature oocytes from animals that were not treated with CLZ (P<0.001). CLZ also improved the survival rates of offspring (P<0.0001). During this study, we formulated the principle that CLZ is not only able to block oocyte maturation and pregnancy but conversely can be utilized to produce oocytes with high developmental levels and fertilization rates. From the contraceptive point of view, CLZ merits further evaluation as a potential non-steroidal contraceptive. From the higher developmental and fertilization point of view, administration of CLZ in superovulation protocols merits continued investigation to address the potential inclusion of CLZ in infertility treatment.
Biography
Ahmed M Taiyeb graduated from the College of Pharmacy/University of Baghdad with an honor degree. During his residency program, he extensively interacted with many scientists and clinicians to study infertility, recurrent abortion, immunological disorder, and hormonal imbalance. He received the medal of IVF Institute for Embryo Research and Infertility Treatment for his recognized contribution at the University of Baghdad. He earned his PhD degree in Reproductive Pharmacology and Medicine from Texas A&M University. He investigated several non-steroidal contraceptive agents using rodents, pigs, and primate animal models for humans. He is currently a Research Associate at Baylor College of Medicine.
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top